Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-22

Clinical Trial Update: Assess the Effect of Metaxalone 640 mg (M640) Compared to Tizanidine 8 mg on Truck Driving Ability and Cognition [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Metaxalone 640 mg (M640) with Tizanidine 8 mg assessing truck driving ability and cognition in cognitive impairment; the study has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metaxalone (metaxalone)
  • TIZANIDINE (TIZANIDINE)

Snippet

Sponsor: Primus Pharmaceuticals | Conditions: Cognitive Impairment | Phase 4 | Status: COMPLETED